Skip to main content

Animations

MJFF Publications

5751 - 5760 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2012
  • 2009
  • 2020
  • 2005
  • 2008
  • 2025
  • 2025
  • 2011
  • 2015
  • Summary Details
    OPEN
    Title: Use of Glycolysis‐Enhancing Drugs and Risk of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29184
    Citation Count: 23
  • Summary Details
    OPEN
    Title: A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182516244
    Citation Count: 325
  • Summary Details
    OPEN
    Title: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.300
    Best OA location URL: http://doi.org/10.1038/ng.300
    Citation Count: 527
  • Summary Details
    OPEN
    Title: The unfolded protein response is activated in the olfactory system in Alzheimer’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-020-00986-7
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
    Journal Name: BMC Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/1471-2202-6-71
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor
    Journal Name: Molecular Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1124/mol.108.048884
    Citation Count: 149
  • Summary Details
    OPEN
    Title: EndoMAP.v1 charts the structural landscape of human early endosome complexes
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-025-09059-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adt2050
    Citation Count: 0
  • Summary Details
    OPEN
    Title: BAX inhibitor‐1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/emboj.2011.318
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Stochastic electrotransport selectively enhances the transport of highly electromobile molecules
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1510133112
    Citation Count: 237
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.